1,550 results on '"Seidah, Nabil"'
Search Results
2. GDF10 is a negative regulator of vascular calcification
3. PCSK9 facilitates melanoma pathogenesis via a network regulating tumor immunity
4. PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease
5. The proprotein convertase SKI-1/S1P is a critical host factor for Nairobi sheep disease virus infectivity
6. Efficient in vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors
7. Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond
8. Molecular interactions of PCSK9 with an inhibitory nanobody, CAP1 and HLA-C: Functional regulation of LDLR levels
9. Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers
10. Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearance
11. SPRING is a Dedicated Licensing Factor for SREBP-Specific Activation by S1P
12. Insights Into PCSK9-LDLR Regulation and Trafficking Via the Differential Functions of MHC-I Proteins HFE and HLA-C
13. Proprotein convertase subtilisin/kexin Type 9 is required for Ahnak-mediated metastasis of melanoma into lung epithelial cells
14. Circulating PCSK9 is associated with liver biomarkers and hepatic steatosis
15. Pcsk9 knockout exacerbates diet-induced non-alcoholic steatohepatitis, fibrosis and liver injury in mice
16. Dengue virus induces PCSK9 expression to alter antiviral responses and disease outcomes
17. Publisher Correction: Efficient in vivo base editing via single adenoassociated viruses with size-optimized genomes encoding compact adenine base editors
18. Insights into PCSK9-LDLR Regulation and Trafficking via the Differential Functions of MHC-I Proteins HFE and HLA-C.
19. Corrigendum to “PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease” [Metabolism Volume 150, January 2024, 155736, PMID: 7967646]
20. PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease
21. Myostatin is a major endocrine driver of follicle-stimulating hormone synthesis
22. Posttranslational modification of proprotein convertase subtilisin/kexin type 9 is differentially regulated in response to distinct cardiometabolic treatments as revealed by targeted proteomics
23. Osteopontin as a novel substrate for the proprotein convertase 5/6 (PCSK5) in bone
24. HIV-induced neuroinflammation: impact of PAR1 and PAR2 processing by Furin
25. The Secretory Proprotein Convertase Neural Apoptosis-Regulated Convertase 1 (NARC-1): Liver Regeneration and Neuronal Differentiation
26. Shedding of cancer susceptibility candidate 4 by the convertases PC7/furin unravels a novel secretory protein implicated in cancer progression
27. The Lassa Virus Glycoprotein Precursor GP-C is Proteolytically Processed by Subtilase SKI-1/S1P
28. Circulating Rather Than Intestinal PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Regulates Postprandial Lipemia in Mice
29. Mammalian Subtilisin/Kexin Isozyme SKI-1: A Widely Expressed Proprotein Convertase with a Unique Cleavage Specificity and Cellular Localization
30. Ser-Phosphorylation of PCSK9 (Proprotein Convertase Subtilisin-Kexin 9) by Fam20C Kinase Enhances Its Ability to Degrade the LDLR (Low-Density Lipoprotein Receptor)
31. The Notch1 Receptor is Cleaved Constitutively by a Furin-Like Convertase
32. Inhibition of proprotein convertase subtilisin-like kexin type 9 (PCSK9) potentiates anti-angiogenic therapy in colorectal cancer liver metastases
33. Abstract 1741: Inhibition of pcsk9 impairs the development of vessel co-option and potentiates anti-angiogenic therapy in colorectal cancer liver metastases
34. Surface LDLR is a major receptor for lipoprotein(a) clearance in male mice lacking PCSK9
35. Impaired Fertility in Mice Deficient for the Testicular Germ-Cell Protease PC4
36. PCSK7: a Novel Regulator of Apolipoprotein B and a Potential Target Against Non-Alcoholic Fatty Liver Disease
37. The Isoforms of Proprotein Convertase PC5 Are Sorted to Different Subcellular Compartments
38. The loss-of-function PCSK[9.sup.Q152H] variant increases ER chaperones GRP78 and GRP94 and protects against liver injury
39. Ser-Phosphorylation of PCSK9 (Proprotein Convertase Subtilisin-Kexin 9) by Fam20C (Family With Sequence Similarity 20, Member C) Kinase Enhances Its Ability to Degrade the LDLR (Low-Density Lipoprotein Receptor)
40. SKI-1/S1P Facilitates SARS-CoV-2 Spike Induced Cell-to-Cell Fusion via Activation of SREBP-2 and Metalloproteases, Whereas PCSK9 Enhances the Degradation of ACE2
41. Mutation Screening of PCSK9 Exons in Iranian Arab Patients Suffering from Familial Hypercholesterolemia
42. Familial hypercholesterolemia mutations in the Middle Eastern and North African region: A need for a national registry
43. Proprotein convertase furin regulates osteocalcin and bone endocrine function
44. PCSK9 in Liver Cancers at the Crossroads between Lipid Metabolism and Immunity
45. SKI-1/S1P Facilitates SARS-CoV-2 Spike Induced Cell-To-Cell Fusion via Activation of Srebp-2 and Metalloproteases, Whereas PCSK9 Enhances the Degradation of ACE2
46. PCSK9 deficiency results in a specific shedding of excess LDLR in female mice only: Role of hepatic cholesterol
47. Molecular interactions of PCSK9 with an inhibitory nanobody, CAP1 and HLA-C: functional regulation of LDLR levels
48. High levels of serum cholesterol positively correlate with the risk of the development of vessel co-opting tumours in colorectal cancer liver metastases
49. The effect of insulin on circulating PCSK9 in postmenopausal obese women
50. Transcriptome Analysis Reveals Nonfoamy Rather Than Foamy Plaque Macrophages Are Proinflammatory in Atherosclerotic Murine Models
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.